The pharmaceutical industry in India was valued at $50 billion in 2024, and is projected to touch $130 billion in 2030. India is the world’s largest supplier of generic drugs,contributing approximately 20% of the total volume,it is also the global leader in vaccines,contributing approximately 60% of the entire supply.From the above it is clear that the development of this industry is inimical to our growth.

Pharmaceutical manufacturing and storage facilities are energy intensive.There are strict temperature controls,energy costs and regulatory compliance which are non negotiable.Cleanrooms,cold chain infrastructures,production units must at all times maintain precise temperatures and humidity levels to protect sensitive active pharmaceutical agents or APIs,vaccines and finished drugs.Even small temperature fluctuations can trigger regulatory deviations and manufacturing failures.Traditional dark or conventional roofs absorb upto 90% of the incipient solar radiation, converting these facilities to heat islands which force the HVAC systems into overdrive, especially in warm climatic zones like India.

Applying LuminX, this dynamic can be reversed.Independent testing has shown results.LuminX coatings can lower surface temperatures by 20-25 degree celcius on a hot day compared to conventional roofs.Reduced heat flux from the roof translates into reduced cooling loads.Peer reviewed studies have demonstrated that energy savings can go as high as 15-30% in pharmaceutical facilities located in climatic zones 1-4( where India lies). Additionally, moisture control is of utmost importance in manufacturing of certain chemical compounds used in medicines. In certain special cases,even the use of a fan is prohibited which might interfere in rates of evaporation and condensation. Under such circumstances where temperatures are to be kept low, moisture maintained without the use of an external agent like a fan,LuminX does the job.The coatings prevent heat and moisture build up in these facilities.

For temperature critical areas such as stability chambers and cold storage warehouses( mostly operating below freezing point), the benefits of using LuminX is even more pronounced.Our esteemed client, an API manufacturer retrofitted 40,000 sqft roof with LuminX and documented a 20% drop in refrigeration compressor runtime,improving temperature uniformity inside the warehouse facility.

Beyond energy savings,LuminX extend the shelf life of roofs by reducing thermal cycling and UV degradation.Most pharmaceutical plants operate under validated commotions wherein any change in unplanned roof replacement triggers paperwork and potential production downtime.The enhanced roof durably thus delivers both financial and regulatory value.

Sustainability reporting is becoming mandatory.Pharmaceutical Companies filing ESG reports under new standards can credit verified reductions under it’s respective categories achieved through emission reductions using LuminX.Several global pharma giants have already included SRI roof coatings in their net zero roadmaps.

LuminX can deliver measurable benefits to the pharmaceutical sector: 15-20% energy savings, improved product temperature stability,extended roof life,reduced regulatory risks and achievable decarbonisation goals.For an industry that spends billions on energy and compliance,LuminX represents one of the simplest,fastest,most cost effective interventions available.